Metabolic comorbidities affect the survival of hepatitis B virus-related hepatocellular carcinoma in Chinese patients: a retrospective cohort study with propensity score matching - Top-Institutions - MDSpire

Metabolic comorbidities affect the survival of hepatitis B virus-related hepatocellular carcinoma in Chinese patients: a retrospective cohort study with propensity score matching

  • By

  • Zheng Zhou

  • Xiyan Zheng

  • Zhiqun Lin

  • Xianqing Chen

  • Maoyun Xie

  • July 14, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Eighth Affiliated Hospital of Sun Yat-sen University
    Eighth Affiliated Hospital of Sun Yat-sen University

    Guangzhou, Guangdong

    Key Differentiators

    • Hepatology

  • #2

    University of Tokyo Medical Research Center
    University of Tokyo Medical Research Center

    Tokyo, Tokyo

    Key Differentiators

    • Hepatology

  • #3

    Beijing You’an Hospital
    Beijing You’an Hospital

    Beijing, Beijing

    Key Differentiators

    • Hepatology

  • #4

    Beijing Ditan Hospital
    Beijing Ditan Hospital

    Beijing, Beijing

    Key Differentiators

    • Hepatology

  • #5

    Yunnan Cancer Hospital
    Yunnan Cancer Hospital

    Kunming, Yunnan

    Key Differentiators

    • Hepatology

Original Source(s)

Metabolic comorbidities affect the survival of hepatitis B virus-related hepatocellular carcinoma in Chinese patients: a retrospective cohort study with propensity score matching

  • by Zheng Zhou, Xiyan Zheng, Zhiqun Lin, Xianqing Chen, Maoyun Xie

  • July 14, 2026

Related Content

Inside VIVEbiotech’s Work with Zelluna on TCR-NK Cell Therapy

VIVEbiotech CEO Jon Alberdi lifts the lid on an eight-year collaboration focused on GMP lentiviral vectors for off-the-shelf solid tumor therapies

  • July 14, 2026

  • 4 min
Tumor-associated macrophages and lineage plasticity in prostate cancer: from established myeloid programs to emerging spatial hypotheses

From Peak Performance to Precision Healthcare

Travis Nemkov and Angelo D’Alessandro discuss how molecular profiling in elite athletes could inform personalized exercise, healthy aging, and cancer recovery